Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
| Autor: | Palmieri, Carlo *, Linden, Hannah, Birrell, Stephen N, Wheelwright, Sally, Lim, Elgene, Schwartzberg, Lee S, Dwyer, Amy R, Hickey, Theresa E, Rugo, Hope S, Cobb, Patrick, O'Shaughnessy, Joyce A, Johnston, Stephen, Brufsky, Adam, Tilley, Wayne D *, Overmoyer, Beth * |
|---|---|
| Zdroj: | In The Lancet Oncology March 2024 25(3):317-325 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|